- Home
- LNT vs RVTY Comparison
LNT vs RVTY Comparison
Compare LNT & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNT | RVTY |
|---|---|---|
| Founded | 1917 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.7B | 16.9B |
| IPO Year | 1999 | 1994 |
Fundamental Metrics
Financial Performance| Metric | LNT | RVTY |
|---|---|---|
| Price | $66.45 | $155.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 18 |
| Target Price | $77.38 | ★ $141.53 |
| AVG Volume (30 Days) | ★ 2.6M | 2.0M |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | ★ 3.25% | 0.18% |
| EPS Growth | ★ 16.73 | N/A |
| EPS | ★ 0.87 | 0.82 |
| Revenue | ★ $4,362,000,000.00 | $3,311,822,000.00 |
| Revenue This Year | $4.65 | N/A |
| Revenue Next Year | $5.84 | $5.40 |
| P/E Ratio | ★ $75.67 | $187.91 |
| Revenue Growth | ★ 9.57 | N/A |
| 52 Week Low | $62.54 | $81.22 |
| 52 Week High | $78.81 | $166.25 |
Technical Indicators
Market Signals| Indicator | LNT | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 55.00 | 67.21 |
| Support Level | $64.93 | $95.28 |
| Resistance Level | $67.80 | N/A |
| Average True Range (ATR) | 0.97 | 5.71 |
| MACD | 0.45 | -0.41 |
| Stochastic Oscillator | 99.37 | 60.03 |
Price Performance
Historical ComparisonAbout LNT Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light. Together, IPL and WPL serve nearly 1 million electric customers and 425,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.